Comparing the Long-term Cost-effectiveness of Repaglinide Plus Metformin Versus Nateglinide Plus Metformin in Type 2 Diabetes Patients with Inadequate Glycaemic Control: An Application of the CORE Diabetes Model in Type 2 Diabetes

By Palmer Andrew J.   Roze Stéphane   Lammert Morten   Valentine William J.   Minshall Michael E.   Nicklasson Lars   Gall Mari-Anne   Spinas Giatgen A.  

Current Medical Research and Opinion, Vol. 20, Iss. 1, 2004-08 ,pp. : 41-51

Informa Healthcare

Access to resources Recommend Favorite

Effects of early use of pioglitazone in combination with metformin in patients with newly diagnosed type 2 diabetes

By Chalmers J.   Hunter J. E.   Robertson S. J.   Baird J.   Martin M.   Franks C. I.   Whately-Smith C. R.   Mariz S.   Campbell I. W.  

Current Medical Research and Opinion, Vol. 23, Iss. 8, 2007-08 ,pp. : 1775-1781

Informa Healthcare

Access to resources Recommend Favorite

Peri‐operative continuation of metformin does not improve glycaemic control in patients with type 2 diabetes: A randomized controlled trial

By  

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 20, Iss. 3, 2018-03 ,pp. : 749-752

John Wiley & Sons Inc

Access to resources Recommend Favorite

Efficacy and safety of initial combination therapy with alogliptin plus metformin versus either as monotherapy in drug‐naïve patients with type 2 diabetes: a randomized, double‐blind, 6‐month study

By  

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 16, Iss. 7, 2014-07 ,pp. : 613-621

John Wiley & Sons Inc

Access to resources Recommend Favorite

Achieving glycemic goal with initial versus sequential combination therapy using metformin and pioglitazone in type 2 diabetes mellitus

By Pandya Bhavik J.   Bron Morgan   McCall Therese   Yu Andrew P.   Chen Kristina S.   Mattson Miles E.   Wu Eric Q.  

Current Medical Research and Opinion, Vol. 27, Iss. 1, 2011-01 ,pp. : 189-195

Informa Healthcare

Access to resources Recommend Favorite